MichaelCMithoeferMD

Psychiatry • Mount Pleasant, SC

Clinical research 75% Clinical practice 25%

Join to view full profile

Dr. Mithoefer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mithoefer's full profile

Already have an account?

Office
208 Scott St
Mount Pleasant, SC 29464
Phone+1 843-849-6899

Fax+1 843-884-3010

Education & Training

Medical University of South CarolinaResidency, Psychiatry, 1991 - 1994
University of Virginia Medical CenterResidency, Internal Medicine, 1977 - 1981
Medical University of South CarolinaClass of 1977

Certifications & Licensure

NC State Medical License 2023 - 2025
SC State Medical License 1981 - 2025
VT State Medical License 1978 - 1996
American Board of Internal Medicine Internal Medicine

Clinical Trials

MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder Start of enrollment: 2004 Mar 12
Completed
Phase 2
Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder Start of enrollment: 2010 Nov 10
Completed
Phase 2
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial Start of enrollment: 2010 Dec 15
Completed
Phase 2
Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD Start of enrollment: 2014 Jan 01
Completed
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD Start of enrollment: 2017 Nov 16
Completed
Phase 2
Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada) Start of enrollment: 2018 Mar 13
Completed
Phase 2
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) Start of enrollment: 2018 Nov 21
Completed
Phase 3
Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study Start of enrollment: 2020 Jun 24
Completed
Phase 2
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2) Start of enrollment: 2020 Sep 02
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized co...
Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner
Psychopharmacology. 2024-11-01
Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
Allison A Feduccia, Lisa Jerome, Michael C Mithoefer, Julie Holland
Psychopharmacology. 2024-11-01
Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
Lisa Jerome, Allison A Feduccia, Julie B Wang, Scott Hamilton, Berra Yazar-Klosinski
Psychopharmacology. 2024-11-01

Press Mentions

FDA Declines to Approve Novel MDMA Therapy to Treat PTSD, with Request for More Trial DataAugust 12th, 2024
How Does Ptsd Work in the BrainAugust 3rd, 2022
Psychedelics in Medicine: Where We Are, Where We're GoingOctober 1st, 2021
Join now to see all

Other Languages

Spanish, French